Abstract：
UNASSIGNED: The \"2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease\" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia).
UNASSIGNED: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate.
UNASSIGNED: Recommendations from the \"2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease\" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
UNASSIGNED: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate.
UNASSIGNED: Recommendations from the \"2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease\" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
摘要：
■\“2024ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS下肢外周动脉疾病管理指南”提供了建议，以指导临床医生在下肢外周动脉疾病患者的多个临床表现子集（即，无症状，慢性症状，慢性威胁肢体缺血，和急性肢体缺血）。
■从2020年10月至2022年6月进行了全面的文献检索，包括研究，reviews,以及PubMed以英文发表的关于人类受试者的其他证据，EMBASE,Cochrane图书馆,CINHL完成，以及与本指南相关的其他选定数据库。其他相关研究，到2023年5月在同行评审过程中发布，也由写作委员会审议，并在适当的情况下添加到证据表中。
■“2016AHA/ACC下肢外周动脉疾病患者管理指南”的建议已更新，并有新的证据指导临床医生。此外,针对外周动脉疾病患者的综合护理提出了新的建议.
■从2020年10月至2022年6月进行了全面的文献检索，包括研究，reviews,以及PubMed以英文发表的关于人类受试者的其他证据，EMBASE,Cochrane图书馆,CINHL完成，以及与本指南相关的其他选定数据库。其他相关研究，到2023年5月在同行评审过程中发布，也由写作委员会审议，并在适当的情况下添加到证据表中。
■“2016AHA/ACC下肢外周动脉疾病患者管理指南”的建议已更新，并有新的证据指导临床医生。此外,针对外周动脉疾病患者的综合护理提出了新的建议.
